Contact us

Support


Eisai

Pharmstandard and Japanese pharmaceutical producer Eisai signed an agreement on the localization of production of anticancer and antiepileptic drug Perampanel in Russia.

31 May 2016
www.remedium-journal.ru
Investor
Republic of Bashkortostan, Kursk Region

Investor profile

Eisai

Japan

Company's website: www.eisai.com

T: 81-3-3817-3700

Public company

Contact: Haruo Naito, Director General

Eisai Co., Ltd. is a Japanese pharmaceutical company, one of the world’s top 30 largest pharmaceutical companies. It employes over 10 thousand workers. Eisai’s Head Office is located in Tokyo, the company also has offices in the US and in Europe.

Subscribe to Newsletters

Email: